Duterte eyes vaccine institute before term ends

President Rodrigo Duterte aims to establish a Vaccine Institute before his term ends in 2022 to enable local vaccine production.

Presidential spokesperson Harry Roque stated that Duterte desires this institute as a legacy to reduce the Philippines' reliance on imported vaccines.

The Department of Science and Technology (DOST) welcomed the intention, with DOST Secretary Fortunato "Boy" T. de la Peña expressing hopes that the proposed institute will focus on vaccine development, potentially as the Virology Science & Technology Institute of the Philippines (VIP).

De la Peña noted that mass production of vaccines could be undertaken by the private sector, a GOCC, or a joint venture.

The initiative comes amidst a significant surge in COVID-19 cases in the Philippines, with over 115,000 active infections reported.

The country has implemented various lockdowns over the past year to curb COVID-19 transmission, with current restrictions in place for Metro Manila and nearby provinces.

The Philippines' COVID-19 vaccination program, which began on March 1, has so far received 2,525,600 doses from Sinovac and AstraZeneca.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.